0000950170-24-016185.txt : 20240216 0000950170-24-016185.hdr.sgml : 20240216 20240216110236 ACCESSION NUMBER: 0000950170-24-016185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Herzich Paul CENTRAL INDEX KEY: 0001954991 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38360 FILM NUMBER: 24646233 MAIL ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: THIRD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solid Biosciences Inc. CENTRAL INDEX KEY: 0001707502 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 900943402 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 BUSINESS PHONE: 617-337-4680 MAIL ADDRESS: STREET 1: 500 RUTHERFORD AVENUE STREET 2: 3RD FLOOR CITY: CHARLESTOWN STATE: MA ZIP: 02129 FORMER COMPANY: FORMER CONFORMED NAME: Solid Biosciences, LLC DATE OF NAME CHANGE: 20170524 4 1 ownership.xml 4 X0508 4 2024-02-13 false 0001707502 Solid Biosciences Inc. SLDB 0001954991 Herzich Paul C/O SOLID BIOSCIENCES INC. 500 RUTHERFORD AVENUE, THIRD FLOOR CHARLESTOWN MA 02129 false true false false Chief Technology Officer false Common Stock 6022 D Employee Stock Option (Right to Buy) 7.85 2024-02-13 4 A false 57500 0.00 A 2034-02-13 Common Stock 57500 57500 D Restricted Stock Units 2024-02-13 4 A false 28750 0.00 A Common Stock 28750 28750 D Includes 1,752 shares of the issuer's common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2023. This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. /s/ David Tyronne Howton as attorney-in-fact for Paul Herzich 2024-02-16